Aurionpro Solutions is undergoing a structural transformation from a traditional IT services provider into a scalable, IP-led fintech and technology powerhouse.
News in Focus


Tata Motors Passenger Vehicles Ltd (TMPV), backed by a BUY recommendation from Geojit Investments Limited, presents a compelling yet nuanced investment narrative.

Emkay Research has issued a BUY recommendation on InterGlobe Aviation (IndiGo), setting a revised target price of Rs5,500, implying a potential upside of approximately 31.5% from the current market

Geojit Financial Services has issued a ‘BUY’ recommendation on CCL Products (India) Ltd., highlighting strong earnings momentum, improving balance sheet strength, and a technically bullish setup.

Emami share price touched 52-week lows during Thursday's trading session but the stock recovered by the end of the day. Emami touched Rs 385.5 but ended the day 1.3 percent higher at Rs 398.5.

Premier Energies, Waaree Energies, ONGC, Oil India shares could see higher levels in upcoming sessions as markets can recover after US President Donald Trump's announcement of withdrawing from Iran
Main Regional Stories

HDFC Securities has reiterated a BUY call on Swiggy, underscoring a compelling valuation opportunity after a sharp ~37% correction over the past six months.

HDFC Securities has upgraded Eternal to a BUY rating, maintaining a target price of Rs 340, signaling a compelling upside from current levels.

Motilal Oswal Financial Services has reiterated a BUY call on Adani Ports & SEZ (APSEZ), with a target price of Rs 1,820, implying an upside potential of nearly 39% from the current market price of Rs 1,313.

Geojit Financial Services has reiterated a BUY call on TTK Prestige Limited, positioning the stock as a compelling opportunity following a sharp valuation correction.
New Delhi: Industry dean Ratan Tata advised that nonattendance of strong uni
New Delhi: Punjab National Bank (PNB) increased its fixed de
In early trading (10:02 am), Advanta India is quoting at Rs 856, up Rs 65.85, or 8.33%. It is swapping with volume of 7,271 shares.
Hyderabad: Cipla Ltd will produce the primary three-in-one cocktail anti-AIDS medicine used for children. This accompanies the USFDA clearing a combining quantity of Boehringer Ingelheim’s Viramune, GlaxoSmithKline’s Epivir (or lamivudine) and Bristol-Myers Squibb’s Zerit (or stavudine), which are anti-retrovirals or drugs that fight back AIDS.








